Notice to Rescind NOT-AA-19-025 "Notice of Intent to Publish a Funding Opportunity Announcement for Early Liver Transplantation Cohort Study (U10 - Clinical Trial Optional) "
Notice NOT-AA-19-030 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 31, 2019 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Early Liver Transplantation Cohort Study (U10 - Clinical Trial Optional)
Notice NOT-AA-19-025 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 10, 2019 Category: Research Source Type: funding
(Re)Building a Kidney (UC2 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-19-007 from the NIH Guide for Grants and Contracts. This FOA invites new applications for the (Re)Building a Kidney (RBK) Consortium. The goal of the RBK is to improve or restore failing kidney function after injury or disease. This FOA invites teams of investigators with complementary expertise to develop and test novel ways to either (1) stimulate productive kidney repair/regeneration in vivo, or (2) generate functional kidney tissue ex vivo for transplantation. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 22, 2019 Category: Research Source Type: funding
(Re)Building a Kidney (UC2 Clinical Trial Not Allowed)
This FOA invites new applications for the (Re)Building a Kidney (RBK) Consortium. The goal of the RBK is to improve or restore failing kidney function after injury or disease. This FOA invites teams of investigators with complementary expertise to develop and test novel ways to either (1) stimulate productive kidney repair/regeneration in vivo, or (2) generate functional kidney tissue ex vivo for transplantation.RFA-DK-19-007 (Source: NIDDK Funding Opportunities)
Source: NIDDK Funding Opportunities - July 22, 2019 Category: Endocrinology Source Type: funding
HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-19-041 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications from investigators to participate in the HLA and KIR Region Genomics in Immune Mediated Diseases Consortium (HLARGC). This cooperative research group supports projects defining the association between variations in the human leukocyte antigen (HLA), also known as the Major Histocompatibility Complex (MHC), and natural killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, including outcomes following cell, tissue, and or...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 2, 2019 Category: Research Source Type: funding
HLA and KIR Region Genomics in Immune-Mediated Diseases (U19 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-19-044 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications from investigators to participate in the HLA and KIR Region Genomics in Immune Mediated Diseases Consortium (HLARGC). This cooperative research group supports projects defining the association between variations in the human leukocyte antigen (HLA), also known as the Major Histocompatibility Complex (MHC), and natural killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, including outcomes following cell, tissue, and or...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 2, 2019 Category: Research Source Type: funding
Request for Information (RFI): Soliciting input for future research at the NHLBI regarding Late complications after allogeneic hematopoietic stem cell transplantation or autologous gene modified stem cell transplant for non-malignant blood disorders
Notice NOT-HL-18-659 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 23, 2018 Category: Research Source Type: funding
Request for Information (RFI): Current Clinical Management and Assessment Practices in Lung Transplantation
Notice NOT-HL-18-653 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 7, 2018 Category: Research Source Type: funding
Expanding Extramural Research Opportunities at the NIH Clinical Center (U01 Clinical Trial Optional)
Funding Opportunity PAR-18-879 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support extramural investigator-initiated clinical research in collaboration and partnership with intramural investigators at the NIH Clinical Center in Bethesda, MD. This new FOA will leverage the resources (inpatient and outpatient) and assets of the NIH Clinical Center (e.g., scientific, clinical trial and expertise, nursing, beds, critical care services, ambulatory care services, laboratories, imaging, biostatistics, protocol development, regulatory guidance, clinical trials management and safety oversight) in a...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 26, 2018 Category: Research Source Type: funding
Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trials Not Allowed)
Funding Opportunity PAR-18-781 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support the use of Collaborative Cross (CC) mouse lines to advance understanding of the host genetics involved in immune regulation and function and to further develop CC mouse lines that more faithfully reproduce human immune responses. Research areas supported by this FOA include: immune system development, function or regulation; mechanisms governing immune response to infectious pathogens, vaccines or adjuvants; host susceptibility factors and mechanisms of pathogen-induced imm...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 11, 2018 Category: Research Source Type: funding
Cooperative Centers on Human Immunology (U19 Clinical Trial Optional)
Funding Opportunity RFA-AI-17-040 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to continue the Cooperative Centers on Human Immunology (CCHI) program to support studies that will advance understanding of the mechanisms regulating human immune responses. The immediate objective of CCHI is to support mechanistic and hypothesis-testing studies to understand human immunity applicable to the biodefense effort; i.e. innate, adaptive and mucosal immune responses to infection, vaccination and adjuvants. Studies on immune-mediated diseases (e.g...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 4, 2017 Category: Research Source Type: funding
Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-091 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to establish a program of research to advance the understanding, prevention and treatment of pediatric multiple organ dysfunction syndrome (MODS). Given the prevalence and associated morbidity and mortality of MODS in children, the current lack of understanding underscores the need for more basic, exploratory and longitudinal research. Possible topics of study include, but are not limited, to the epidemiology, pathophysiology, monitoring, and treatment of MODS. Studies that assess spe...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 6, 2017 Category: Research Source Type: funding
Notice of Participation of National Institute of Allergy and Infectious Diseases (NIAID) on RFA-CA-17-031 " Limited Competition: A Data Resource for Analyzing Blood and Marrow Transplants (U24)
Notice NOT-AI-17-038 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 23, 2017 Category: Research Source Type: funding
Limited Competition: A Data Resource for Analyzing Blood and Marrow Transplants (U24)
Funding Opportunity RFA-CA-17-031 from the NIH Guide for Grants and Contracts. The purpose of this limited competition Funding Opportunity Announcement (FOA) is to solicit the Center for International Blood and Marrow Transplant Research (CIBMTR) a limited competition application for the continued support of the Data Resource for Analyzing Blood and Marrow Transplants program. The support for this FOA is to ensure the continued availability of the CIBMTR database as a resource to investigators, transplant physicians, and healthcare policy-makers. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 15, 2017 Category: Research Source Type: funding
Reintroduction of Trifolium amoenum at Ring Mountain
The objective of the project is to compare survival and fitness of the two ecotypes of the species and to compare establishment success of seeding versus transplants. If successful, the project would have a clear benefit in that it would drastically increase the range and would protect the species from stochastic events that could affect the single natural population at Dillon Beach, Marin County. Submitted to the U.S. Fish and Wildlife Service (Service)â¿¿s CFDA Program 15.657, this award is approved and made under the authority of: Endangered Species Act of 1973, 16 U.S.C. 1531 et. seq, as amended.Version: Synopsis 1...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Natural Resources Source Type: funding
